Bunji Sato

773 citations
24 papers · 563 indexed · h-index 12
Topics
Microbial Natural Products and Biosynthesis (7 papers)Bioactive Compounds and Antitumor Agents (6 papers)Herpesvirus Infections and Treatments (5 papers)

In The Last Decade

Bunji Sato

23 papers receiving 551 citations

Peers

Bunji Sato
Comparison fields: 5 of 66
  • Molecular Biology 266
  • Organic Chemistry 165
  • Pharmacology 146
  • Epidemiology 98
  • Biotechnology 84
Replace Aline Primot with:
Aline Primot France
Sadafumi Ohmura Japan
Michio Yamagishi Japan
C.M. Tsiapalis Greece
Helga Wessner Germany
Laureen Colis United States
A. Jane Bardwell United States
Claus Rudolph Germany
Jayant Asthana India
Bunji Sato relative to Aline Primot France Aline Primot's profile →
Citations per field
00.5×7.0×
Aline Primot · 1×
Citations per year

Countries citing papers authored by Bunji Sato

Since Specialization
Citations

This map shows the geographic impact of Bunji Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bunji Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bunji Sato more than expected).

Fields of papers citing papers by Bunji Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bunji Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bunji Sato. The network helps show where Bunji Sato may publish in the future.

Co-authorship network of co-authors of Bunji Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Bunji Sato. A scholar is included among the top collaborators of Bunji Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bunji Sato. Bunji Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 31
2 4
3 1
4 1
5 33
6 18
7 7
8 15
9 1
10 50
11 16
12 71
13 56
14 1
15 35
16 154
17 4
18 7
19
Structure and function of FGF receptor 1 and its expression mechanism
0
20 18

About Bunji Sato

Bunji Sato is a scholar working on Toxicology, Biotechnology and Pharmacology, having authored 24 papers that have together received 563 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Biotechnology (84 citations), Pharmacology (146 citations) and Virology (28 citations). Bunji Sato has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Hiroshi Terano, Shigehiro Takase, Hidenori Nakajima, Takashi Fujita, MASAKUNI OKUHARA, Seiji Yoshimura, Takayoshi Kinoshita, Ann M. Arvin, Marvin Sommer and Seiji Hashimoto. Their work appears in journals such as Journal of Virology, Biochemical and Biophysical Research Communications and Bone.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026